Oncology & Hematolgy: Enabling Better Outcomes for Patients and Sponsors (Chapter 2 of 6)

Adam Callahan discusses how adaptability and early planning can help sponsors balance protocol requirements with the burden placed on patients participating in oncology and hematology trials. Patients may already face frequent clinical visits, infusions, blood draws, biopsies, imaging, and other demanding procedures while undergoing treatment. Adam explains how thoughtful trial design can support the collection of necessary safety and efficacy data while accounting for these realities. He also describes Caidya’s personalized, highly engaged approach to sponsor relationships and shares the personal experiences that motivate his work in clinical development. The discussion reflects a broader commitment to advancing novel therapies for patients with unmet medical needs.